Literature DB >> 21602054

T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules.

Navtej Kaur1, Osama S Naga, Håkan Norell, Amir A Al-Khami, Matthew J Scheffel, Nitya G Chakraborty, Christina Voelkel-Johnson, Bijay Mukherji, Shikhar Mehrotra.   

Abstract

Persistence of effector cytotoxic T lymphocytes (CTLs) during an immunological response is critical for successfully controlling a viral infection or tumor growth. Various cytokines are known to play an important part in regulating the immune response. The IL-2 family of cytokines that includes IL-2 and IL-15 are known to function as growth and survival factors for antigen-experienced T cells. IL-2 and IL-15 possess similar properties, including the ability to induce T cell proliferation. Whereas long-term IL-2 exposure has been shown to promote apoptosis and limit CD8(+) memory T cell survival and proliferation, it is widely believed that IL-15 can inhibit apoptosis and helps maintain a memory CD8(+) T-cell population. However, mechanisms for superior outcomes for IL-15 as compared to IL-2 are still under investigation. Our data shows that human T cells cultured in the presence of IL-15 exhibit increased expression of anti-oxidant molecules glutathione reductase (GSR), thioredoxin reductase 1 (TXNDR1), peroxiredoxin (PRDX) and superoxide dismutase (SOD). An increased expression of cell-surface thiols, intracellular glutathione, and thioredoxins was also noted in IL-15 cultured T cells. Additionally, IL-15 cultured T cells showed an increase in cytolytic effector molecules. Apart from increased level of Granzyme A and Granzyme B, IL-15 cultured T cells exhibited increased accumulation of reactive oxygen (ROS) and reactive nitrogen species (RNS) as compared to IL-2 cultured T cells. Overall, this study suggests that T cells cultured in IL-15 show increased persistence not only due to levels of anti-apoptotic proteins, but also due to increased anti-oxidant levels, which is complimented by increased cytolytic effector functions.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602054      PMCID: PMC3595556          DOI: 10.1016/j.cyto.2011.04.014

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  81 in total

Review 1.  Control of T helper cell differentiation--in search of master genes.

Authors:  C Dong; R A Flavell
Journal:  Sci STKE       Date:  2000-09-12

2.  Preventing apoptosis with thioredoxin: ASK me how.

Authors:  Nanette H Bishopric; Keith A Webster
Journal:  Circ Res       Date:  2002-06-28       Impact factor: 17.367

3.  Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells.

Authors:  Susanne J Szabo; Brandon M Sullivan; Claudia Stemmann; Abhay R Satoskar; Barry P Sleckman; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

Review 4.  The IL-2/IL-15 receptor systems: targets for immunotherapy.

Authors:  Thomas A Waldmann
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

5.  Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis.

Authors:  Toru Tanaka; Fumihito Hosoi; Yuko Yamaguchi-Iwai; Hajime Nakamura; Hiroshi Masutani; Shugo Ueda; Akira Nishiyama; Shunichi Takeda; Hiromi Wada; Giannis Spyrou; Junji Yodoi
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

6.  IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells.

Authors:  Kebin Liu; Marta Catalfamo; Yu Li; Pierre A Henkart; Nan-ping Weng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

7.  Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis.

Authors:  Protul Shrikant; Matthew F Mescher
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

8.  Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death.

Authors:  Min Li-Weber; Markus A Weigand; Marco Giaisi; Dorothee Süss; Monika K Treiber; Sven Baumann; Elena Ritsou; Raoul Breitkreutz; Peter H Krammer
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).

Authors:  Yoichi Ohiro; Igor Garkavtsev; Shinichiro Kobayashi; Kodangattil R Sreekumar; Regan Nantz; Bryan T Higashikubo; Shannon L Duffy; Ryuji Higashikubo; Anny Usheva; David Gius; Nikolai Kley; Nobuo Horikoshi
Journal:  FEBS Lett       Date:  2002-07-31       Impact factor: 4.124

Review 10.  The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases.

Authors:  Thomas Waldmann
Journal:  Arthritis Res       Date:  2002-05-09
View more
  15 in total

1.  Anti-oxidant capacity and anti-tumor T cell function: A direct correlation.

Authors:  Pravin Kesarwani; Krishnamurthy Thyagarajan; Shilpak Chatterjee; Viswanathan Palanisamy; Shikhar Mehrotra
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

Review 2.  Redox regulation of T-cell function: from molecular mechanisms to significance in human health and disease.

Authors:  Pravin Kesarwani; Anuradha K Murali; Amir A Al-Khami; Shikhar Mehrotra
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

Review 3.  The Role of NADPH Oxidases in the Etiology of Obesity and Metabolic Syndrome: Contribution of Individual Isoforms and Cell Biology.

Authors:  Evan DeVallance; Yao Li; Michael J Jurczak; Eugenia Cifuentes-Pagano; Patrick J Pagano
Journal:  Antioxid Redox Signal       Date:  2019-10-01       Impact factor: 8.401

4.  IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

Authors:  Yumeng Mao; Vincent van Hoef; Xiaonan Zhang; Erik Wennerberg; Julie Lorent; Kristina Witt; Laia Masvidal; Shuo Liang; Shannon Murray; Ola Larsson; Rolf Kiessling; Andreas Lundqvist
Journal:  Blood       Date:  2016-07-27       Impact factor: 22.113

5.  Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells.

Authors:  Ying Yang; Shi Yong Neo; Ziqing Chen; Weiyingqi Cui; Yi Chen; Min Guo; Yongfang Wang; Haiyan Xu; Annina Kurzay; Evren Alici; Lars Holmgren; Felix Haglund; Kai Wang; Andreas Lundqvist
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

6.  IL-15 maintains T-cell survival via S-nitrosylation-mediated inhibition of caspase-3.

Authors:  P T Saligrama; K A Fortner; M A Secinaro; C C Collins; J Q Russell; R C Budd
Journal:  Cell Death Differ       Date:  2014-02-07       Impact factor: 15.828

7.  IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype.

Authors:  Darya Alizadeh; Robyn A Wong; Xin Yang; Dongrui Wang; Joseph R Pecoraro; Cheng-Fu Kuo; Brenda Aguilar; Yue Qi; David K Ann; Renate Starr; Ryan Urak; Xiuli Wang; Stephen J Forman; Christine E Brown
Journal:  Cancer Immunol Res       Date:  2019-03-19       Impact factor: 11.151

8.  Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death.

Authors:  Stefan Brunner; Dietmar Herndler-Brandstetter; Christoph R Arnold; Gerrit Jan Wiegers; Andreas Villunger; Matthias Hackl; Johannes Grillari; María Moreno-Villanueva; Alexander Bürkle; Beatrix Grubeck-Loebenstein
Journal:  Aging Cell       Date:  2012-04-18       Impact factor: 9.304

Review 9.  The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension.

Authors:  Cassandra M Moshfegh; Adam J Case
Journal:  Antioxid Redox Signal       Date:  2020-04-30       Impact factor: 8.401

10.  Potential limitations of the NSG humanized mouse as a model system to optimize engineered human T cell therapy for cancer.

Authors:  Erik M Alcantar-Orozco; Hannah Gornall; Vania Baldan; Robert E Hawkins; David E Gilham
Journal:  Hum Gene Ther Methods       Date:  2013-08-24       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.